0001144204-12-006433.txt : 20120207
0001144204-12-006433.hdr.sgml : 20120207
20120207171701
ACCESSION NUMBER: 0001144204-12-006433
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20120207
DATE AS OF CHANGE: 20120207
EFFECTIVENESS DATE: 20120207
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-173040
FILM NUMBER: 12578754
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
D
1
primary_doc.xml
X0704
D
LIVE
0001059784
GENEREX BIOTECHNOLOGY CORP
33 HARBOUR SQ
SUITE 202
TORONTO
A6
ONTARIO, CANADA
M5J 2G2
4163642551
DELAWARE
None
None
Corporation
true
Mark
A.
Fletcher
33 HARBOUR SQUARE
SUITE 202
TORONTO
A6
ONTARIO, CANADA
M5J 2G2
Executive Officer
Director
Nola
E.
Masterson
33 HARBOUR SQUARE
SUITE 202
TORONTO
A6
ONTARIO, CANADA
M5J 2G2
Director
Eric
von Hofe, Ph.D.
33 HARBOUR SQUARE
SUITE 202
TORONTO
A6
ONTARIO, CANADA
M5J 2G2
Director
James
H.
Anderson, Jr., M.D.
33 HARBOUR SQUARE
SUITE 202
TORONTO
A6
ONTARIO, CANADA
M5J 2G2
Director
Stephen
Fellows
33 HARBOUR SQUARE
SUITE 202
TORONTO
A6
ONTARIO, CANADA
M5J 2G2
Executive Officer
David
Brusegard, Ph.D.
33 HARBOUR SQUARE
SUITE 202
TORONTO
A6
ONTARIO, CANADA
M5J 2G2
Executive Officer
John
P.
Barratt
33 HARBOUR SQUARE
SUITE 202
TORONTO
A6
ONTARIO, CANADA
M5J 2G2
Director
Brian
T.
McGee
33 HARBOUR SQUARE
TORONTO
A6
ONTARIO, CANADA
M5J 2G2
Director
Pharmaceuticals
$1 - $1,000,000
- 06
false
2012-02-01
false
true
true
true
false
50000
Seahawk Capital Partners, Inc.
None
None
None
147 MAIN STREET, SECOND FLOOR
COLD SPRING HARBOR
NY
NEW YORK
11724
NJ
NEW JERSEY
NY
NEW YORK
false
2000000
2000000
0
false
7
0
160000
0
false
GENEREX BIOTECHNOLOGY CORP
/s/ Mark A. Fletcher
Mark A. Fletcher
President
2012-02-06